1,2-dipalmitoylphosphatidylcholine has been researched along with Pulmonary Hypertension in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahsan, F; Gupta, N; Gupta, V; Komatsu, M; McMurtry, IF; Mehvar, R; Nozik-Grayck, E; Oka, M; Shaik, IH | 1 |
| Bakowsky, U; Gessler, T; Kissel, T; Kleemann, E; Schmehl, T; Seeger, W | 1 |
| Greenspan, JS; Shaffer, TH; Wolfson, MR | 1 |
3 other study(ies) available for 1,2-dipalmitoylphosphatidylcholine and Pulmonary Hypertension
| Article | Year |
|---|---|
Liposomal fasudil, a rho-kinase inhibitor, for prolonged pulmonary preferential vasodilation in pulmonary arterial hypertension.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; 1,2-Dipalmitoylphosphatidylcholine; Aerosols; Alkaline Phosphatase; Animals; Bronchoalveolar Lavage Fluid; Cell Line; Cell Survival; Cholesterol; Drug Stability; Familial Primary Pulmonary Hypertension; Hypertension, Pulmonary; L-Lactate Dehydrogenase; Liposomes; Macrophages, Alveolar; Male; Myocytes, Smooth Muscle; Protein Kinase Inhibitors; Pulmonary Artery; Rats; Rats, Sprague-Dawley; rho-Associated Kinases; Vasodilation; Vasodilator Agents | 2013 |
Iloprost-containing liposomes for aerosol application in pulmonary arterial hypertension: formulation aspects and stability.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Administration, Inhalation; Aerosols; Calorimetry, Differential Scanning; Chemistry, Pharmaceutical; Cholesterol; Drug Carriers; Drug Compounding; Drug Stability; Excipients; Hypertension, Pulmonary; Iloprost; Liposomes; Microscopy, Atomic Force; Nebulizers and Vaporizers; Particle Size; Polyethylene Glycols; Pulmonary Alveoli; Ultrasonics; Vasodilator Agents | 2007 |
Pulmonary administration of vasoactive substances by perfluorochemical ventilation.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Acetylcholine; Acid-Base Equilibrium; Administration, Inhalation; Adrenergic alpha-Antagonists; Animals; Animals, Newborn; Blood Pressure; Dose-Response Relationship, Drug; Epinephrine; Fluorocarbons; Heart Rate; Hypertension, Pulmonary; Hypoxia; Injections, Intravenous; Lung; Pulmonary Gas Exchange; Respiration, Artificial; Sheep; Tolazoline; Vasoconstrictor Agents; Vasodilator Agents | 1996 |